FGEN - FIBROGEN INC
IEX Last Trade
0.5669
-0.009 -1.517%
Share volume: 11,207
Last Updated: Fri 27 Dec 2024 08:29:42 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$0.58
-0.01
-1.49%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-07 | 2023-02-27 | 2023-05-08 | 2023-08-07 | 2023-11-06 | 2024-02-26 | 2024-05-06 | |
| Assets | |||||||||
| Total Assets | 686.789 M | 608.837 M | 610.087 M | 538.544 M | 515.127 M | 460.426 M | 423.529 M | 365.868 M | |
| Current Assets | 520.643 M | 474.224 M | 492.826 M | 430.549 M | 411.357 M | 364.108 M | 331.559 M | 278.167 M | |
| Inventories | 40.899 M | 39.950 M | 40.436 M | 42.456 M | 41.179 M | 40.696 M | 41.565 M | 27.335 M | |
| Other Current Assets | 8.038 M | 10.426 M | 14.083 M | 14.490 M | 8.863 M | 40.378 M | 41.855 M | 36.150 M | |
| Short Term Investments | 8.038 M | 10.426 M | 14.083 M | 14.490 M | 8.863 M | 40.378 M | 41.855 M | 36.150 M | |
| Total Receivables | 33.573 M | 15.328 M | 16.299 M | 17.654 M | 25.599 M | 31.694 M | 12.553 M | 37.083 M | |
| Current Cash | 438.133 M | 408.520 M | 422.008 M | 355.949 M | 335.716 M | 251.340 M | 235.586 M | 177.599 M | |
| Total Non-current Assets | 166.146 M | 134.613 M | 117.261 M | 107.995 M | 103.770 M | 96.318 M | 91.970 M | 87.701 M | |
| Property Plant Equipment | 24.505 M | 22.287 M | 20.605 M | 18.693 M | 16.829 M | 14.512 M | 13.126 M | 12.166 M | |
| Other Assets | 4.501 M | 4.940 M | 5.282 M | 4.672 M | 4.353 M | 3.952 M | 3.803 M | 3.350 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 686.789 M | 608.837 M | 610.087 M | 538.544 M | 515.127 M | 460.426 M | 423.529 M | 365.868 M | |
| Total liabilities | 583.009 M | 582.531 M | 631.534 M | 587.396 M | 617.401 M | 617.595 M | 627.695 M | 593.990 M | |
| Total current liabilities | 240.340 M | 251.994 M | 273.562 M | 254.746 M | 194.072 M | 209.415 M | 217.668 M | 196.733 M | |
| Accounts Payable | 29.360 M | 19.323 M | 30.758 M | 71.282 M | 12.802 M | 19.220 M | 17.960 M | 4.353 M | |
| Other liabilities | 239.622 M | 229.479 M | 258.412 M | 235.798 M | 236.141 M | 224.512 M | 229.589 M | 220.566 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 71.408 M | 71.666 M | 71.934 M | 72.213 M | |
| Other liabilities | 239.622 M | 229.479 M | 258.412 M | 235.798 M | 236.141 M | 224.512 M | 229.589 M | 220.566 M | |
| Minority interest | 19.967 M | 19.967 M | 19.967 M | 19.967 M | 41.967 M | 41.967 M | 41.967 M | 41.967 M | |
| Total Shareholder equity | 103.780 M | 26.306 M | -21.447 M | -48.852 M | -102.274 M | -157.169 M | -204.166 M | -228.122 M | |
| Common stock | 93.475 M | 93.767 M | 94.043 M | 94.691 M | 97.729 M | 98.245 M | 98.547 M | 98.982 M | |
| Retained earnings | -1.400 B | -1.492 B | -1.558 B | -1.634 B | -1.722 B | -1.786 B | -1.842 B | -1.875 B |